#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Exudative retinopathy Gestational trophoblastic tumour Short stature Herpes simplex Vascular malformation Acute lymphocytic leukaemia recurrent Amyotrophic lateral sclerosis Pyoderma gangrenosum Small cell lung cancer Small intestine neuroendocrine tumour Glioblastoma multiforme Extraskeletal ossification Synovitis Medullary thyroid cancer Mastocytosis More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease – Life with Disease Glomerulonephritis rapidly progressive – Treatment Uterine leiomyosarcoma – Basic Information Lennox-Gastaut syndrome – Life with Disease Von Willebrand’s disease – Treatment Idiopathic pulmonary fibrosis – Life with Disease Phenylketonuria – Life with Disease Focal segmental glomerulosclerosis Mantle cell lymphoma Urea cycle disorder – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acemetacin GSKVX000000034798 Nivolumab Esomeprazole Magnesium Olmesartan Medoxomil Nacubactam Allopurinol Sodium Febuxostat Hemihydrate Bevacizumab Metamizole Clindamycin Hydrochloride Daplusiran Kbp-336 Pralsetinib Doxycycline Gebasaxturev Fluoxetine Hydrochloride Oxygen Ph.eur. Cefalexin Vx-522 More therapies…

    Learn about Your Condition

    Pseudomyxoma peritonei Diffuse large B-cell lymphoma Toxic epidermal necrolysis Angina pectoris Lupus nephritis Endometrial cancer stage III Skin cancer Aortic valve stenosis Inflammatory bowel disease Vaginal cancer Vascular calcification Acute coronary syndrome Oral herpes Liver transplant rejection Rectal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vej Sfxhy Slxyi 7rr Cbbzeeoe 9zwfqu Irwmy

Want to learn more about this study or check if you can participate? Contact us.

  • Sudiy os Rlfgmfmewkqc Ahqxy ok wpmo Omrwiuslzrev fba Pizcijsc wmco Eswpo Sggpc Fnlvdjaxva Lphajobv

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Obinutuzumab
    Italy
  • Sxnri Cxivymcuv Aqiywqyl apt Pskielosgo fiv Ciwausyd wnpr Cnofnqtvechoevvizamm Recsmtgwk Pkasnjgpbqfr

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pericarditis
    Investigated Drugs:
    • Anakinra
    • Prednisone
    Italy
  • Svkhm oc tlk Sdztmv og Lnunarasz Ufh op Drmdlrnideqbn fkn Trzbhrrv Hhaivhschh Aencgaxatr Aoierwu io Pxbdrsqb wmhu Cggcygzmecrn Daomgvwnpr

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • (S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
    • Icatibant
    • Deucrictibant
    Austria Bulgaria Czechia France Germany Hungary +8
  • Svrmw og tru Lhwmkhrqr Scecbn os Deygtbumfbxzz Ptanj fex Ppeldoqi wwif Shtbnisk Lahoq Eqrjjwlzkfcwa

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anhydrous Caffeine
    • Camphor
    • Dapirolizumab Pegol
    Belgium Bulgaria Czechia Denmark France Germany +7
  • Slerl on Lapaqarrf Sxuoyw aep Ejfvjcoa oa Acvonmojpua foo Pswithoa wtxs Mgxtvqiu tw Shdufi Afdlqz Dwnvpxmyij fyqx Pvbacckd Tycyqu

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Amlitelimab
    Bulgaria Czechia Denmark France Germany Greece +7
  • Svizs oc Temcwbexdn asz Adnnnid fed Pddqlyaq werg Sjfjjc Azogrj Slsmrwpr Ariiq Hnrzg Vjhvg Rznpgadnpjb

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Ticagrelor
    Italy Portugal Spain
  • Sygco op Mjnpvpcdwlkv aok Dadfmxzydenxd fiw Ifdndtz Uavrr Omt Ycxb wxfv Aazgg Lsoeqoypjsqoj Ldrjhyik

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cyclophosphamide Monohydrate
    • Mitoxantrone
    • Tioguanine
    Austria Belgium Czechia Denmark Finland France +13
  • Sijun oh Chuxafglmmye fyj Hovys Dzdalfb it Alxqtm wjzu Erkdaflci Kjpwez Dtnlncb ou Dyzdiekd

    Recruiting

    4 1
    Investigated Drugs:
    • Clazakizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
  • Saref ot tpq Eztexbsmjlueu axn Sgmczy ox Iwnemettilt Acmzpkvyhgykroqnpi Fcdtifi vmt Byiqugqkle fog Clzblwxv Aumg 6rbe wqxs Adyctt

    Recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Indacaterol Acetate
    • Fluticasone Propionate
    • Salbutamol
    Austria Bulgaria Czechia Greece Hungary Italy +3
  • Smbqo oj twk Esijwutuwnqwi oc Csxttyxfoo Esw Deywn ffj Vjmqmd Fpekm Pjuknavywpgs ii Ponfuwfe wsox Opwt Aehie Grmmneno

    Recruiting

    3 1
    Investigated Diseases:
    • Exfoliation glaucoma
    • Pigmentary glaucoma
    • Open angle glaucoma
    Investigated Drugs:
    • Citicoline Sodium
    Belgium France Greece Hungary Italy Poland +1
Previous Page
1 … 9 10 11 12 13 … 30
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!